Hepatitis Monthly

Published by: Kowsar

Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction

Maryam Moini 1 , Mazyar Ziyaeyan 2 , Shapoor Aghaei 3 , Mohammad Mahdi Sagheb 4 , * , Seyed Alireza Taghavi 1 , Mahsa Moeini 2 , Marzieh Jamalidoust 2 and Laleh Hamidpour 1
Authors Information
1 Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Internal Medicine, Yasouj University of Medical Sciences, Yasouj, IR Iran
4 Nephrourology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: May 01, 2013, 13 (6); e9147
  • Published Online: May 30, 2013
  • Article Type: Research Article
  • Received: December 7, 2012
  • Revised: February 1, 2013
  • Accepted: February 17, 2013
  • DOI: 10.5812/hepatmon.9147

To Cite: Moini M, Ziyaeyan M, Aghaei S, Sagheb M M, Taghavi S A, et al. Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction, Hepat Mon. 2013 ;13(6):e9147. doi: 10.5812/hepatmon.9147.

Abstract
Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P. Hepatitis C virus infection and the dialysis patient. Semin Dial. 2007; 20(5): 416-22[DOI][PubMed]
  • 2. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004; 39(4): 1147-71[PubMed]
  • 3. Donahue JG, Munoz A, Ness PM, Brown DE, Jr., Yawn DH, McAllister HA, Jr., et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992; 327(6): 369-73[DOI][PubMed]
  • 4. Lok AS, Chien D, Choo QL, Chan TM, Chiu EK, Cheng IK, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology. 1993; 18(3): 497-502[PubMed]
  • 5. Bouzgarrou N, Fodha I, Othman SB, Achour A, Grattard F, Trabelsi A, et al. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol. 2005; 77(4): 502-8[DOI][PubMed]
  • 6. Fabrizi F, Lunghi G, Aucella F, Mangano S, Barbisoni F, Bisegna S, et al. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol. 2005; 43(1): 414-20[DOI][PubMed]
  • 7. Medhi S, Potukuchi SK, Polipalli SK, Swargiary SS, Deka P, Chaudhary A, et al. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Clin Biochem. 2008; 41(7-8): 447-52[DOI][PubMed]
  • 8. Miedouge M, Saune K, Kamar N, Rieu M, Rostaing L, Izopet J. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol. 2010; 48(1): 18-21[DOI][PubMed]
  • 9. Reddy AK, Dakshinamurty KV, Lakshmi V. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol. 2006; 24(1): 55-7[PubMed]
  • 10. Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int. 2010; 14(3): 253-62[DOI][PubMed]
  • 11. Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007; 14(10): 697-703[DOI][PubMed]
  • 12. Scott DR, Wong JK, Spicer TS, Dent H, Mensah FK, McDonald S, et al. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation. 2010; 90(11): 1165-71[DOI][PubMed]
  • 13. Rostami Z, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B. The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation. Hepat Mon. 2011; 11(4): 247-54[PubMed]
  • 14. Fabrizi F, Lunghi G, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther. 2006; 24(10): 1413-22[DOI][PubMed]
  • 15. Werner T, Aqel B, Balan V, Byrne T, Carey E, Douglas D, et al. Treatment of hepatitis C in renal transplantation candidates: a single-center experience. Transplantation. 2010; 90(4): 407-11[DOI][PubMed]
  • 16. Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, et al. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology. 1996; 110(4): 1120-6[PubMed]
  • 17. Zidan A, Scheuerlein H, Schule S, Settmacher U, Rauchfuss F. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon. 2012; 12(10 HCC)[DOI][PubMed]
  • 18. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010; 14 Suppl 3-6[DOI][PubMed]
  • 19. Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol. 2008; 28(4): 628-40[DOI][PubMed]
  • 20. El-Sherif A, Elbahrawy A, Aboelfotoh A, Abdelkarim M, Saied Mohammad AG, Abdallah AM, et al. High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis. Hemodial Int. 2012; 16(3): 420-7[DOI][PubMed]
  • 21. Hussein MM, Mooij JM, Hegazy MS, Bamaga MS. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit. Saudi J Kidney Dis Transpl. 2007; 18(1): 107-13[PubMed]
  • 22. Makhlough A, Jamshidi M, Mahdavi MR. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran. Singapore Med J. 2008; 49(11): 921-3[PubMed]
  • 23. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, et al. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol. 2001; 75(17): 8240-50[PubMed]
  • 24. Tanaka T, Lau JY, Mizokami M, Orito E, Tanaka E, Kiyosawa K, et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol. 1995; 23(6): 742-5[PubMed]
  • 25. Orito E, Mizokami M, Tanaka T, Lau JY, Suzuki K, Yamauchi M, et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut. 1996; 39(6): 876-80[PubMed]
  • 26. Aoyagi K, Ohue C, Iida K, Kimura T, Tanaka E, Kiyosawa K, et al. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol. 1999; 37(6): 1802-8[PubMed]
  • 27. Widell A, Molnegren V, Pieksma F, Calmann M, Peterson J, Lee SR. Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase. Transfus Med. 2002; 12(2): 107-13[PubMed]
  • 28. Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, et al. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. J Med Virol. 2004; 73(3): 397-403[DOI][PubMed]
  • 29. Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology. 2000; 32(2): 388-93[DOI][PubMed]
  • 30. Icardi G, Ansaldi F, Bruzzone BM, Durando P, Lee S, de Luigi C, et al. Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen. J Clin Microbiol. 2001; 39(9): 3110-4[PubMed]
  • 31. Courouce AM, Le Marrec N, Bouchardeau F, Razer A, Maniez M, Laperche S, et al. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion. 2000; 40(10): 1198-202[PubMed]
  • 32. Li Cavoli G, Zagarrigo C, Schillaci O, Servillo F, Tralongo A, Coglitore M, et al. Hepatitis C virus core antigen test in monitoring of dialysis patients. Hepat Res Treat. 2012; 2012: 832021[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments